BioCentury
ARTICLE | Clinical News

C: Phase Ib data

October 7, 2013 7:00 AM UTC

Valneva said data from the Phase Ib portion of an open-label, dose-escalation, Austrian and Hungarian Phase I trial in 81 healthy volunteers >65 years of age showed that 4 vaccinations with 75 and 200...